Maternal Obesity, Inflammation, and Developmental Programming

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2014 Jun 27

PMID 24967364

Citations 91

Authors

Stephanie A Segovia

Mark H Vickers

Clint Gray

Clare M Reynolds

Affiliations

Soon will be listed here.

Abstract

The prevalence of obesity, especially in women of child-bearing age, is a global health concern. In addition to increasing the immediate risk of gestational complications, there is accumulating evidence that maternal obesity also has long-term consequences for the offspring. The concept of developmental programming describes the process in which an environmental stimulus, including altered nutrition, during critical periods of development can program alterations in organogenesis, tissue development, and metabolism, predisposing offspring to obesity and metabolic and cardiovascular disorders in later life. Although the mechanisms underpinning programming of metabolic disorders remain poorly defined, it has become increasingly clear that low-grade inflammation is associated with obesity and its comorbidities. This review will discuss maternal metainflammation as a mediator of programming in insulin sensitive tissues in offspring. Use of nutritional anti-inflammatories in pregnancy including omega 3 fatty acids, resveratrol, curcumin, and taurine may provide beneficial intervention strategies to ameliorate maternal obesity-induced programming.

Citing Articles

Unbalanced Diets: High-Fat, High-Sucrose and High-Protein Diets.

Reynes B, Palou M Nutrients. 2025; 17(4).

PMID: 40004983 PMC: 11858411. DOI: 10.3390/nu17040655.

Maternal Overweight and Obesity and Risk of Perinatal Ischemic Stroke: A Nationwide Cohort Study.

Walas A, Simatou E, Andersson Franko M, Persson M, Stephansson O, Razaz N Neurology. 2025; 104(6):e213333.

PMID: 39983062 PMC: 11867210. DOI: 10.1212/WNL.0000000000213333.

Maternal Dietary Improvement or Leptin Supplementation During Suckling Mitigates the Long-Term Impact of Maternal Obesogenic Conditions on Inflammatory and Oxidative Stress Biomarkers in the Offspring of Diet-Induced Obese Rats.

Pomar C, Trepiana J, Besne-Eseverri I, Castillo P, Palou A, Palou M Int J Mol Sci. 2024; 25(22).

PMID: 39595945 PMC: 11594198. DOI: 10.3390/ijms252211876.

Beyond the Scale: Exploring the Endocannabinoid System's Impact on Obesity.

Akurati S, Hanlon E Curr Diab Rep. 2024; 25(1):6.

PMID: 39543055 DOI: 10.1007/s11892-024-01562-2.

Metabolic abnormalities in the bone marrow cells of young offspring born to mothers with obesity.

Phillips E, Alharithi Y, Kadam L, Coussens L, Kumar S, Maloyan A Int J Obes (Lond). 2024; 48(11):1542-1551.

PMID: 38937647 DOI: 10.1038/s41366-024-01563-x.

References

Schaiff W, Knapp Jr F, Barak Y, Biron-Shental T, Nelson D, Sadovsky Y . Ligand-activated peroxisome proliferator activated receptor gamma alters placental morphology and placental fatty acid uptake in mice. Endocrinology. 2007; 148(8):3625-34. DOI: 10.1210/en.2007-0211. View

Sun M, Zhao Y, Gu Y, Xu C . Anti-inflammatory mechanism of taurine against ischemic stroke is related to down-regulation of PARP and NF-κB. Amino Acids. 2011; 42(5):1735-47. DOI: 10.1007/s00726-011-0885-3. View

Shankar K, Harrell A, Liu X, Gilchrist J, Ronis M, Badger T . Maternal obesity at conception programs obesity in the offspring. Am J Physiol Regul Integr Comp Physiol. 2007; 294(2):R528-38. DOI: 10.1152/ajpregu.00316.2007. View

Lillycrop K, Phillips E, Jackson A, Hanson M, Burdge G . Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr. 2005; 135(6):1382-6. DOI: 10.1093/jn/135.6.1382. View

Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K . Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes. 2007; 56(4):901-11. DOI: 10.2337/db06-0911. View

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

Oliver E, McGillicuddy F, Harford K, Reynolds C, Phillips C, Ferguson J . Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. J Nutr Biochem. 2011; 23(9):1192-200. DOI: 10.1016/j.jnutbio.2011.06.014. View

Li M, Reynolds C, Sloboda D, Gray C, Vickers M . Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity. PLoS One. 2013; 8(10):e76961. PMC: 3798342. DOI: 10.1371/journal.pone.0076961. View

Dandona P, Aljada A, Bandyopadhyay A . Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2003; 25(1):4-7. DOI: 10.1016/j.it.2003.10.013. View

10.

Singh S, Aggarwal B . Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem. 1995; 270(42):24995-5000. DOI: 10.1074/jbc.270.42.24995. View

11.

Radulescu L, Munteanu O, Popa F, Cirstoiu M . The implications and consequences of maternal obesity on fetal intrauterine growth restriction. J Med Life. 2013; 6(3):292-8. PMC: 3806033. View

12.

Flegal K, Carroll M, Ogden C, Curtin L . Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303(3):235-41. DOI: 10.1001/jama.2009.2014. View

13.

Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat C . Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J. 2004; 18(14):1657-69. DOI: 10.1096/fj.04-2204com. View

14.

Younossi Z, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H . Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011; 9(6):524-530.e1. DOI: 10.1016/j.cgh.2011.03.020. View

15.

Neschen S, Morino K, Dong J, Wang-Fischer Y, Cline G, Romanelli A . n-3 Fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-alpha-dependent manner. Diabetes. 2007; 56(4):1034-41. DOI: 10.2337/db06-1206. View

16.

Bahia L, Aguiar L, Villela N, Bottino D, Godoy-Matos A, Geloneze B . Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clinics (Sao Paulo). 2006; 61(5):433-40. DOI: 10.1590/s1807-59322006000500010. View

17.

Skurk T, Alberti-Huber C, Herder C, Hauner H . Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab. 2006; 92(3):1023-33. DOI: 10.1210/jc.2006-1055. View

18.

Howitz K, Bitterman K, Cohen H, Lamming D, Lavu S, Wood J . Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425(6954):191-6. DOI: 10.1038/nature01960. View

19.

Stewart M, Heerwagen M, Friedman J . Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the"first hit". Clin Obstet Gynecol. 2013; 56(3):577-90. PMC: 3763993. DOI: 10.1097/GRF.0b013e3182a09760. View

20.

Reynolds C, Li M, Gray C, Vickers M . Pre-weaning growth hormone treatment ameliorates bone marrow macrophage inflammation in adult male rat offspring following maternal undernutrition. PLoS One. 2013; 8(7):e68262. PMC: 3699531. DOI: 10.1371/journal.pone.0068262. View